載入...
Bevacizumab for the Treatment of Recurrent Glioblastoma
Despite advances in upfront therapy, the prognosis in the great majority of patients with glioblastoma (GBM) is poor as almost all recur and result in disease-related death. Glioblastoma are highly vascularized cancers with elevated expression levels of vascular endothelial growth factor (VEGF), the...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Libertas Academica
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3095028/ https://ncbi.nlm.nih.gov/pubmed/21603247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S7232 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|